VIDEO: Ocuphire Pharma shares latest in ophthalmic pipeline

ByJay S. Pepose, MD, PhD

ByDavid W. Mullin

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Jay S. Pepose, MD, PhD, shares an update on some of the ophthalmic agents that Ocuphire Pharma has in the pipeline.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Pepose reports being chief medical advisor of Ocuphire Pharma.

Read more about

refractive surgery

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment